Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cervical cancer screening in Taiwan:

This article was originally published in Clinica

Executive Summary

Under Taiwan's national health insurance programme, women aged 30 and over are eligible for an annual Pap smear test. Entitlement drops to once every three years if the woman has a negative result for three consecutive years. Take-up rate for cervical cancer screening during the first year of the country's health insurance scheme was around 12.5%, Dr Yue-Chune Lee of the NHI Task Force revealed at the recent Pan-Asian Healthcare Summit in Singapore.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT088139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel